Industry News
L.A.'s CicLAvia significantly improves air quality in host neighborhoods
10/20/2015
Even one-day 'car-free' events can reduce presence of harmful particulate matterDue in large part to the high volume of traffic that clogs the city's streets and freeways, Los Angeles' air...
Studies address psychological and behavioral aspects of cancer care
10/20/2015
A special issue of Psycho-Oncology highlights the behavioral aspects of cancer care, which involves care provided by clinicians including psychiatrists, psychologists, nurses, and social workers.
Risks of LDCT LC screenings need to be assessed in 20- to 29-pack-year smokers
10/20/2015
The potential risks and harms of low-dose CT (LDCT) lung cancer screening in current 20- to 29-pack-year smokers needs to be assessed before recommending LDCT to this group, according to a study...
Number of moles on right arm could predict risk of deadly skin cancer
10/20/2015
Researchers suggests the risk of melanoma skin cancer may be predicted by the number of moles a person has on their right arm - a finding they say could be useful for doctors.
Leukemia cells can kill each other, study finds
10/20/2015
Scientists have stumbled upon a way to make leukemia cells kill each other, through the application of antibodies. In lab conditions, 15% of cells were killed in 24 hours.
Risks of LDCT LC screenings need to be assessed in 20- to 29-pack-year smokers
10/20/2015
The potential risks and harms of low-dose CT (LDCT) lung cancer screening in current 20- to 29-pack-year smokers needs to be assessed before recommending LDCT to this group, according to a study...
Number of moles on right arm could predict risk of deadly skin cancer
10/20/2015
Researchers suggests the risk of melanoma skin cancer may be predicted by the number of moles a person has on their right arm - a finding they say could be useful for doctors.
Leukemia cells can kill each other, study finds
10/20/2015
Scientists have stumbled upon a way to make leukemia cells kill each other, through the application of antibodies. In lab conditions, 15% of cells were killed in 24 hours.
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa
10/19/2015
The U.S. Food and Drug Administration has granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency...
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa
10/19/2015
The U.S. Food and Drug Administration has granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency...